Abstract:1631 Objectives: Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the degeneration of dopaminergic neurons in the substantia nigra of the brain. Stem cell therapy holds great promise as a potential treatment strategy to produce functional neurons from human pluripotent stem cells (PSCs). A strategy of using PSC-derived dopamine neurons modified to express active or inhibitory forms of DREADD (designer receptors exclusively activated by designer drugs) has been developed to evaluate therapeutic potential for PD treatment in the rhesus monkey model. PET radiotracers of [C-11]clozapine and [C-11]raclopride were used to investigate alterations in binding patterns in the endogenous dopamine competition following treatment with the exogenous designer drug clozapine-N-oxide (CNO). Methods: Five rhesus monkeys underwent a unilateral intracarotid artery injection of MPTP targeting the right substantia nigra or putamen. All monkeys received unilateral intracerebral injections of PSCs with guidance from real-time intraoperative magnetic resonance imaging (RT-IMRI) performed in a 3-T GE SIGNA MRI scanner. Daily doses of CNO were administered to the monkeys to activate the DREADDs expressed by the PSC-derived neurons. Four monkeys underwent [C-11]clozapine scans and one monkey underwent a [C-11]raclopride scan on a microPET Focus 220 scanner. Dynamic data were acquired for 90 minutes post-injection of [C-11]clozapine, and a 120 minute bolus+infusion scan of [C-11]raclopride to assess dopamine release during CNO activation. Regions of interest (ROIs) were drawn for the left putamen, right putamen and cerebellum. Time activity curves (TACs) were generated for each ROI for a semi-quantitative comparison of bilateral differences in putamen uptake following treatment. Results: Asymmetries between the left and right putamen were noticed in the PET data for the [C-11]clozapine scans. Two monkeys showed unilateral uptake of radiotracer with no uptake in the right putamen. The remaining showed bilateral uptake of radiotracer in both the left and right putamen following treatment. The [C-11]raclopride results showed bilateral uptake of radiotracer with elevated uptake in the right putamen following the administration of CNO indicating alteration in dopaminergic function. Conclusions: These qualitative results show the potential for evaluation of PSC-derived neuronal function using PET methodologies. The semi-quantitative analysis will be confirmed through histology studies to show the precise location and effectiveness of PSC engraftment at restoring neuronal function.

In-vivo PET Imaging of Implanted Human Retinal Pigment Epithelium Cells in a Parkinson's Disease Rat Model.

In vivo PET imaging of implanted cells in a Parkinson's disease rat model

Intrastriatal Transplantation of Retinal Pigment Epithelial Cells for the Treatment of Parkinson Disease: in Vivo Longitudinal Molecular Imaging With18f-P3bza PET/CT

11 C-NMSP/ 18 F-FDG Micropet to Monitor Neural Stem Cell Transplantation in a Rat Model of Traumatic Brain Injury

Intrastriatal transplantation of retinal pigment epithelial cells for the treatment of Parkinson disease: in vivo longitudinal molecular imaging with 18F-P3BZA PET/CT.

Transplantation of human retinal pigment epithelium cells in the treatment for Parkinson disease.

Pet Demonstrates Functional Recovery after Transplantation of Induced Pluripotent Stem Cells in A Rat Model of Cerebral Ischemic Injury

Differentiation of Adult Human Retinal Pigment Epithelial Cells into Dopaminergic-Like Cells in Vitro and in the Recipient Monkey Brain

[Positron Emission Tomography Imaging of Cell Transplantation in a Rat Model of Alzheimer's Disease].

[A study of microPET for assessing regional cerebral glucose metabolism and the expression of dopamine receptor type 2 in a rat model of Parkinson's disease].

Spatiotemporal Pet Imaging Of Dynamic Metabolic Changes After Therapeutic Approaches Of Induced Pluripotent Stem Cells, Neuronal Stem Cells, And A Chinese Patent Medicine In Stroke

Therapeutic effect of microencapsulated porcine retinal pigmented epithelial cells transplantation on rat model of Parkinson’s disease

Xenotransplantation of microencapsulated bovine retinal pigment epithelial cells into parkinsonian rats

Using PET Methods to Evaluate Induced Pluripotent Stem Cell-Derived Neuronal Function

Assessing in Vitro Stem‐cell Function and Tracking Engraftment of Stem Cells in Ischaemic Hearts by Using Novel Irfp Gene Labelling

In Vivo Evaluation of Cerebral Transplantation of Resovist-Labeled Bone Marrow Stromal Cells in Parkinson’s Disease Rats Using Magnetic Resonance Imaging

In Vivo Visualization and Monitoring of Viable Neural Stem Cells Using Noninvasive Bioluminescence Imaging in the 6-Hydroxydopamine-Induced Mouse Model of Parkinson Disease

In Vivo Dynamic Metabolic Changes after Transplantation of Induced Pluripotent Stem Cells for Ischemic Injury

[Subretinal Transplantation of Genetically Modified Human Retinal Pigment Epithelium Cells Delay Photoreceptor Degeneration and Functional Deterioration in Rats].

Dopamine Transporter PET Imaging in the Evaluation of Parkinson's Disease Rat Model

In Vivo Detection of Monoaminergic Degeneration in Lipopolysaccharide-Induced Rat Model of Parkinson's Disease Using 18F-FP-(+)-DTBZ (18F-AV-133) PET